Covering effective weight-loss treatments like GLP-1 drugs could lower these costs, ultimately alleviating the financial burden of obesity-related diseases on insurers, employers, and taxpayers alike
Avoid lying down immediately after eating, and stay away from greasy, fried, or very spicy foods as they can worsen symptoms
CrossRef Hepatic inflammation after exposure to a mixture of low-dose arsenic and cadmium in a murine model of fatty liver disease Nivetha K Subramaniam, Natascha Gagnon, Cynthia Guilbert, Rushmi Perinpanathan, Madelyn Abraham, Christophe Goncalves, Jaymie R Meliker, Sonia Del Rincon, Koren K Mann Toxicological Sciences .2026;[Epub] CrossRef Human placenta extract declines fat deposition in an in vitro novel 3D MASLD model Parisa Taheri, Fatemeh Majidi, Kosar Nouri, Masoumeh Nouri, Morteza Zarrabi, Elham Rismani, Abbas Piryaei, Massoud Vosough In vitro models .2026;[Epub] CrossRef DNMT1 facilitates the progression of metabolic dysfunction-associated steatotic liver disease by impeding transcription mediated by HNF4 and PPAR Hyun Ahm Sohn, Hanyong Go, Tae Hyeon An, Jun Min Lee, Hee-Jin Kim, Keeok Haam, Amal Magdy, Hyo-Jung Jung, Yang-Ji Shin, Hyun Jung Lim, Yujin Jeong, Yejin Bae, Youngae Jung, Seong-Hwan Park, Kyung Chan Park, Myeong Jun Song, Eun-Wie Cho, Eun-Soo Kwon, Jeon Clinical and Molecular Hepatology .2026
GLP-1RAs approved for use in the treatment of T2DM include semaglutide, liraglutide, and dulaglutide
